{
  "trial_id": "NCT06710223",
  "title": "Cryoablation and Arterial Infusion of SD-101 in Combination with Durvalumab and Tremelimumab",
  "condition": "Hepatocellular Carcinoma",
  "participant_count": 20,
  "bias_type": "mixed",
  "age_distribution": {
    "mean": 49.45,
    "std": 12.750541784154652,
    "min": 25,
    "max": 76
  },
  "gender_distribution": {
    "male": 0.4853906624010231,
    "female": 0.5146093375989769
  },
  "ethnicity_distribution": {
    "white": 0.7,
    "black": 0.15,
    "asian": 0.1,
    "hispanic": 0.04,
    "other": 0.01
  },
  "sample_size": 20,
  "eligibility_score": 0.8130536651632138
}